Psychomotor and rewarding properties of the neurosteroids dehydroepiandrosterone sulphate and androsterone: Effects on monoamine and steroid metabolism

• Autorzy: Zajda M.E. , Krzascik P. , Hill M. , Majewska M. D.
• Języki publikacji: EN

Abstrakty

EN

The neurosteroids, dehydroepiandrosterone sulfate (DHEAS) and androsterone, are implicated in drug addictions. We examined their influence on locomotor activity and reward in male Wistar rats, and on steroid and monoamine metabolism in the hippocampus and striatum. In the open field test, DHEAS injections (10, 40, 80 mg/kg, i.p.) 30 min prior the test had no significant effect on ambulation, but androsterone (10 mg/kg) increased general locomotion and at doses 1-10 mg/kg, increased central field activity, suggestive of an anxiolytic action. In the conditioned place preference test, both steroids had a biphasic effect: DHEAS was rewarding at doses of 10 and 40 mg/kg, but not at 80 mg/kg, while androsterone was rewarding at doses of 1 and 10 mg/kg, but aversive at 40 mg/kg. Monoamine and steroid concentrations were analyzed in homogenates from the hippocampus and striatum of DHEAS and androsterone injected rats. DHEAS reduced the hippocampal dopamine level, increased striatal homovanilic acid (HVA) and decreased the striatal serotonin concentrations. Androsterone did not affect dopamine levels or turnover, but increased noradrenaline concentration and serotonin turnover in the hippocampus. DHEAS administration augmented concentrations of DHEA, pregnenolone, androstendiol and androstentriol in both brain structures, while androsterone injections increased brain levels of androsterone, epiandrosterone, 5a-dihydrotestosterone, and androstandiol. Present data document that although psychobehavioral and neurochemical effects of DHEAS and androsterone differ in several aspects; both neurosteroids have rewarding properties at certain dose ranges, suggesting their likely involvement in addictions, which entail different mechanisms.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2012
• Tom: 72
• Numer: 1
• Opis fizyczny: p.65-79,fig.,ref.

Twórcy

autor

Zajda M.E.

• Department of Neurology, Medical University of Warsaw, Warsaw, Poland
• Marie Curie Program (EC), Department of Pharmacology and Physiology of the Nervous System, Institute of Psychiatry and Neurology, Warsaw, Poland

autor

Krzascik P.

• Department of Clinical and Experimental Pharmacology, Medical University of Warsaw, Warsaw, Poland

autor

Hill M.

• Department of Steroid Hormones, Institute of Endocrinology, Prague, Czech Republic

autor

Majewska M. D.

• Marie Curie Program (EC), Department of Pharmacology and Physiology of the Nervous System, Institute of Psychiatry and Neurology, Warsaw, Poland

Bibliografia

• Bäckström T, Zetterlund B, Blom S, Romano M (1984) Effects of intravenous progesterone infusions on the epi¬leptic discharge frequency in women with partial epilep¬sy. Acta Neurol Scand 69: 240-248.
• Bahrke MS, Yesalis CE (2004) Abuse of anabolic andro- genic steroids and related substances in sport and exer¬cise. Curr Opin Pharmacol 4: 614-620.
• Baulieu EE, Robel P (1998) Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci U S A 95: 4089-4091.
• Biagini G, Baldelli E, Longo D, Pradelli L, Zini I, Rogawski MA, Avoli M (2006) Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol 201: 519-524.
• Budziszewska B, Jaworska-Feil L, Lasoń W (1996) Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur Neuropsychopharmacol 6: 135-140.
• Chen L, Miyamoto Y, Furuya K, Dai XN, Mori N, Sokabe M (2006) Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplifica¬tion of Src-dependent NMDA receptor signaling. Neuropharmacology 51: 659-670.
• Crawley JN (1985) Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9: 37-44.
• Członkowska AI, Krzaścik P, Sienkiewicz-Jaros H, Siemiqtkowski M, Szyndler J, Maciejak P, Bidziński A, Plaźnik A (2001) Rapid down-regulation of GABA-A receptors after pretreatment of mice with progesterone. Pol J Pharmacol 53: 385-388.
• Członkowska AI, Sienkiewicz-Jarosz H, Siemiatkowski M, Bidziński A, Płaźnik A (1999) The effects of neuroster¬oids on rat behavior and 3H-muscimol binding in the brain. Pharmacol Biochem Behav 63: 639-646.
• Damianisch K, Rupprecht R, Lancel M (2001) The influence of subchronic administration of the neurosteroid allopreg- nanolone on sleep in the rat. Neuropsychopharmacology 25: 576-584.
• de Beun R, Jansen E, Smeets MA, Niesing J, Slangen JL, van de Poll NE (1991) Estradiol-induced conditioned taste aversion and place aversion in rats: sex- and dose- dependent effects. Physiol Behav 50: 995-1000.
• Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430¬434.
• Edgar DM, Seidel WF, Gee KW, Lan NC, Field G, Xia H, Hawkinson JE, Wieland S, Carter RB, Wood PL (1997) CCD-3693: an orally bioavailable analog of the endoge¬nous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat. J Pharmacol Exp Ther 282: 420-429.
• Enomoto M, Adachi H, Fukami A, Furuki K, Satoh A, Otsuka M, Kumagae S, Nanjo Y, Shigetoh Y, Imaizumi T (2008) Serum dehydroepiandrosterone sulfate levels pre¬dict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study). J Am Geriatr Soc 56: 994-998.
• Ffrench-Mullen JM, Danks P, Spence KT (1994) Neurosteroids modulate calcium currents in hippocampal CA1 neurons via a pertussis toxin-sensitive G-protein- coupled mechanism. J Neurosci 14: 1963-1977.
• Flicker C, Geyer MA (1982) Behavior during hippocampal microinfusions. I. Norepinephrine and diversive explora¬tion. Brain Res 257: 79-103.
• Frye CA, Koonce CJ, Edinger KL, Osborne DM, Walf AA (2008) Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm Behav 54: 726--734.
• Frye CA, Lacey EH (1999) The neurosteroids DHEA and DHEAS may influence cognitive performance by altering affective state. Physiol Behav 66: 85-92.
• Frye CA, Park D, Tanaka M, Rosellini R, Svare B (2001) The testosterone metabolite and neurosteroid 3alpha-an- drostanediol may mediate the effects of testosterone on conditioned place preference. Psychoneuroendocrinology 26: 731-750.
• Gage FH, Springer JE (1981) Behavioral assessment of nor- epinephrine and serotonin function and interaction in the hippocampal formation. Pharmacol Biochem Behav 14: 815-821.
• Gauvin DV, Dormer KN, Holloway FA (1991) Pentylenetetrazol can induce a conditioned place prefer¬ence. Pharmacol Biochem Behav 40: 987-990.
• Haren MT, Malmstrom TK, Banks WA, Patrick P, Miller DK, Morley JE (2007) Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas 57: 347-360.
• Harrison NL, Majewska MD, Harrington JW, Barker JL (1987) Structure-activity relationships for steroid interac¬tion with the y-aminobutyric acid A receptor complex. J Pharmacol Exp Ther 241: 346-353.
• Herzog AG (1995) Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45: 1660-1662.
• Hill M, Parizek A, Kancheva R, Duskova M, Velikova M, Kriz L, Klimkova M, Paskova A, Zizka Z, Matucha P, Meloun M, Starka L (2010) Steroid metabolome in plas¬ma from the umbilical artery, umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor. J Steroid Biochem Mol Biol 121: 594-610.
• Huppert FA, Van Niekerk JK (2001) Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst Rev (2):CD000304. [Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD000304.]
• Jacobs AR, Edelheit PB, Coleman AE, Herzog AG (1999) Late-onset congenital adrenal hyperplasia: a treatable cause of anxiety. Biol Psychiatry 46: 856-859.
• Johansson P, Ray A, Zhou Q, Huang W, Karlsson K, Nyberg F (1997) Anabolic androgenic steroids increase beta-endorphin levels in the ventral tegmental area in the male rat brain. Neurosci Res 27: 185-189.
• Jorge JC, Velazquez KT, Ramos-Ortolaza DL, Lorenzini I, Marrero J, Maldonado-Vlaar CS (2005) A testosterone metabolite is rewarding to ovariectomized female rats. Behav Neurosci 119: 1222-1226.
• Kaminski RM, Gasior M, Carter RB, Witkin JM (2003) Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice. Eur J Pharmacol 474: 217¬222.
• Kaneda N, Asano M, Nagatsu T (1986) Simple method for the simultaneous determination of acetylcholine, choline, noradrenaline, dopamine and serotonin in brain tissue by high-performance liquid chromatography with electro¬chemical detection. J Chromatogr 360: 211-218.
• King BE, Packard MG, Alexander GM (1999) Affective properties of intra-medial preoptic area injections of tes¬tosterone in male rats. Neurosci Lett 269: 149-152.
• Kokate TG, Cohen AL, Karp E, Rogawski MA (1996) Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35: 1049-1056.
• Kolomanska P, Wyszogrodzka E, Rok-Bujko P, Krzascik P, Kostowski W, Zaniewska M, Filip M, Stefanski R (2011) Neonatal serotonin (5-HT) depletion does not disrupt prepulse inhibition of the startle response in rats. Pharmacol Rep 63: 1077-1084.
• Kostowski W, Bidzinski A, Krzascik P, Szyndler J, Rok P, Kolomanska P, Wislowska A, Lehner M, Plaznik A. Age- dependent effects of 5,7-dihydroxytryptamine on sero¬tonin transporter in different brain areas in the rat. Pol J Pharmacol. 2004 Jul-Aug;56(4):383-9.
• Lancel M, Faulhaber J, Schiffelholz T, Romeo E, Di Michele F, Holsboer F, Rupprecht R (1997) Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther 282: 1213-1218.
• Ma YY, Yu P, Guo CY, Cui CL (2011) Effects of ifenprodil on morphine-induced conditioned place preference and spatial learning and memory in rats. Neurochem Res 36: 383-391.
• Majewska MD, Demirgoren S, Spivak CE, London ED (1990) The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABA-A receptor. Brain Res 526: 143D146.
• Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate¬like modulators of the GABA receptor. Science 232: 1004-1007.
• Majewska MD (1995) Neuronal actions of dehydroepi- androsterone. Possible roles in brain development, aging, memory, and affect. Ann N Y Acad Sci 774: 111-120.
• Majewska MD (1992) Neurosteroids: endogenous bimodal modulators of the GABA A receptor. Mechanism of action and physiological significance. Prog Neurobiol 38: 379-395.
• Melchior CL, Ritzman RF (1994) Dehydroepiandrosterone is an anxiolytic in mice on the plus-maze. Pharmacol Biochem Behav 47: 437-441.
• Mendelson WB, Martin JV, Perlis M, Wagner R, Majewska MD, Paul SM (1987) Sleep induction by an adrenal ste¬roid in the rat. Psychopharmacology (Berl) 93: 226-229.
• Monnet FP, Mahé V, Robel P, Baulieu EE (1995) Neurosteroids, via sigma receptors, modulate the [3H] norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A 92: 3774-3778.
• Morales AJ, Nolan JJ, Nelson JC, Yen SS (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78: 1360-1267.
• Nguyen T, Porter J, Svec F (1999) Dehydroepiandrosterone (DHEA) decreases open-field spontaneous activity of Zucker rats. Physiol Behav 67: 725-731.
• Packard MG, Schroeder JP, Alexander GM (1998) Expression of testosterone conditioned place preference is blocked by peripheralor intra-accumbens injection of alpha-flu- penthixol. Horm Behav 34: 39-47.
• Parrilla-Carrero J, Figueroa O, Lugo A, García-Sosa R, Brito-Vargas P, Cruz B, Rivera M, Barreto-Estrada JL (2009) The anabolic steroids testosterone propionate and nandrolone, but not 17alpha-methyltestosterone, induce conditioned place preference in adult mice. Drug Alcohol Depend 100:122-127.
• Pérez-Neri I, Méndez-Sánchez I, Montes S, Ríos C (2008a) Acute dehydroepiandrosterone treatment exerts different effects on dopamine and serotonin turnover ratios in the rat corpus striatum and nucleus accumbens. Prog Neuropsychopharmacol Biol Psychiatry 32: 1584-1589.
• Pérez-Neri I, Montes S, Ojeda-López C, Ramírez-Bermúdez J, Ríos C (2008b) Modulation of neurotransmitter sys¬tems by dehydroepiandrosterone and dehydroepiandros- terone sulfate: mechanism of action and relevance to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 32: 1118-1130.
• Plaznik A, Danysz W, Kostowski W (1983) Some behav¬ioral effects of microinjections of noradrenaline and sero¬tonin into the hippocampus of the rat. Physiol Behav 31: 625-631.
• Pytel M, Mercik K, Mozrzymas JW (2006) Interaction between cyclodextrin and neuronal membrane results in modulation of GABA(A) receptor conformational transi¬tions. Br J Pharmacol 148: 413-422.
• Reddy DS, Kulkarni SK (1997) Chronic neurosteroid treat¬ment prevents the development of morphine tolerance and attenuates abstinence behavior in mice. Eur J Pharmacol 337: 19-25.
• Robel P, Baulieu EE (1994) Neurosteroids biosynthesis and function. Trends Endocrinol Metab 5: 1-8.
• Rok-Bujko P, Krząścik P, Szyndler J, Kostowski W, Stefański R (2012) The influence of neonatal serotonin depletion on emotional and exploratory behaviours in rats. Behav Brain Res 226: 87-95.
• Romieu P, Martin-Fardon R, Bowen WD, Maurice T (2003) Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward. J Neurosci 23: 3572-3576.
• Rosellini RA, Svare, BB, Rhodes ME, Frye CA (2001) The testosterone metabolite and neurosteroid 3alpha-andros- tanediol may mediate the effects of testosterone on condi¬tioned place preference. Brain Res Rev 37: 162-171.
• Russo SJ, Sun WL, Minerly AC, Weierstall K, Nazarian A, Festa ED, Niyomchai T, Akhavan A, Luine V, Jenab S, Quinones-Jenab V (2008) Progesterone attenuates cocaine-induced conditioned place preference in female rats. Brain Res 1189: 229-235.
• Shoptaw S, Majewska MD, Wilkins J, Twitchell G, Yang X, Ling W (2004) Participants receiving dehydroepiandros- terone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study. Exp Clin Psychopharmacol 12: 126-135.
• Söderpalm B, Svensson L, Hulthe P, Johannessen K, Engel JA (1991) Evidence for a role for dopamine in the diazepam locomotor stimulating effect. Psychopharmacology (Berl) 104: 97-102.
• Spyraki C, Kazandjian A, Varonos D (1985) Diazepam- induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacology (Berl) 87: 225-232.
• Steinpreis RE, Rutell AL, Parrett FA (1996) Methadone pro¬duces conditioned place preference in the rat. Pharmacol Biochem Behav 54: 339-341.
• Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR (1999) Endocrine, neuroendocrine and behavioral effects of oral dehydroe¬piandrosterone sulfate supplementation in postmeno¬pausal women. Gynecol Endocrinol 13: 15-25.
• Subhan F, Deslandes PN, Pache DM, Swell RD (2000) Do antidepressants affect motivation in conditioned place preference Eur J Pharmacol 408: 257-263.
• Takahashi H, Takada Y, Nagai N, Urano T, Takada A (2000) Serotonergic neurons projecting to hippocampus activate locomotion. Brain Res 869: 194-202.
• Ueda H, Yoshida A, Tokuyama S, Mizuno K, Maruo J, Matsuno K, Mita S (2001) Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane. Neurosci Res 41: 33-40.
• Widgiz SL, Beck CH (1990) Diazepam effects on the exploratory behaviour of rats in an elevated runway: evi¬dence for biphasic effects of benzodiazepines. Behav Brain Res 40: 109-118.
• Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D, Setoda D (2005) DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuroendocrinol ogy 30: 18-28.
• Wood RI (2004) Reinforcing aspects of androgen. Physiol Behav 83: 279-289.
• Yadid G, Sudai E, Maayan R, Gispan I, Weizman A (2010) The role of dehydroepiandrosterone (DHEA) in drug- seeking behavior. Neurosci Biobehav Rev 35: 303-314.

Uwagi

Rekord w opracowaniu